ATTENTION ESSA Pharma Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into ESSA Pharma Inc. for potential violations of federal securities laws. This follows ESSA's announcement of ending its Phase 2 trial for a prostate cancer treatment.
November 14, 2024 | 10:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ESSA Pharma Inc. is under investigation by Levi & Korsinsky for potential securities law violations after halting a Phase 2 trial for a prostate cancer treatment.
The investigation into potential securities law violations and the halting of a Phase 2 trial are significant negative news for ESSA Pharma. This could lead to a loss of investor confidence and a potential drop in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100